Scientific Sessions 2014 Preliminary Program - (Page 4)

Preliminary Program PRogRAM sEssIoNs* Acute and Chronic Complications * What Are Appropriate Blood Pressure Targets in Diabetic Kidney Disease? * The Conundrum of Diabetic Neuropathies * The Big Picture-Diabetic Retinopathy Detection, Treatment, and Tomorrow's Therapies * Diabetic Kidney Disease-What's in the Current and Future Toolbox? * Joint ADA/ASN Symposium-Diabetes and Advanced Chronic Kidney Disease-Diabetologists and Nephrologists on the Front Line * Reducing the Rate of Major Amputation-Talk and Action * The Enigmatic Charcot Foot * Consequences/Impact of Hypoglycemia * Prevention of Hypoglycemia * Diabetic Dyslipidemia-New Insights and Emerging Therapies * Novel Mediators of Cardiovascular Disease in Diabetes * Pharmacogenomics, Diabetes, and Cardiovascular Disease Behavioral Medicine, Clinical Nutrition, Education, and Exercise * Benefits of Exercise without Weight Loss-Can We Forget the Scale? * Back to the Future-Diabetes Education in the Changing Health Care Environment * Diabetes Education-Riding the Waves of Change * Moving On Up-Supporting Transitions * How Can We Help? Strategies for Behavior Change and Effective Coping * Bending the Curve-Behavioral Health Efforts in Diabetes and Health Care Reform * Complications-The Human Side * Peer Support Programs around the World * Stop Eating-Why That Prescription Does Not Work * More Than a Gut Feeling-The Role of Gut Bacteria in Diabetes and Obesity * New Diabetes Nutrition Therapy Guidelines- The Evidence, Controversies, and Application to Practice * From Insecure to Secure-Improving Nutrition in Vulnerable Populations with Diabetes * Is Clinical Diabetes Research Malnourished? The Value of Including Nutrition in Diabetes Research * Variation in the Response to Exercise-Does Everyone Benefit from Exercise? * Exercise for Diabetes-Go Hard, Go Easy, or Just Get Off the Couch? 4 Clinical Diabetes/Therapeutics * Implications of the Affordable Care Act for Diabetes * Can Better Control of HbA1c Reduce Cardiovascular Risk? * Getting the Patient Perspective on Diabetes * Public Initiatives to Improve Health * The Endocrinologist, the Primary Care Physician, and the Nurse Practitioner-Who Does What in the New Health Care World? * Liver Disease in Diabetes * Update on the Assessment and Management of Microvascular Complications for the Practicing Clinician * The Role of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes * The Need for a Better Basal-What's on the Horizon * New Type 1 Diabetes Guidelines-Are They Enough? * Closed-Loop Insulin Delivery-One Step at a Time * New Frontiers in Inpatient Diabetes Management * Hypoglycemia and Cardiovascular Disease- Lessons from Outcome Studies * Subtypes of Type 2 Diabetes in Adults * Initial Treatment of Type 2 Diabetes-New and NotSo-New Ideas * Can We Limit the Long-term Decline of Beta Cells in Type 2 Diabetes? * Cardiovascular Outcomes in Recent Diabetes Trials * Longer-term Consequences of Gestational Diabetes on Offspring * Making an Impact in Gestational Diabetes * Developmental Programming or Developmental Origins of Health and Disease (DOHaD) * The SEARCH for Diabetes Complications in TODAY's Youth * Obesity in Our Youth * Strategies for a Pathway for Drugs and Devices for Pediatric Diabetes Care * Joint ADA/AACC Symposium-Self-Monitoring of Blood Glucose-21st-Century Issues * ADA Diabetes Care Symposium-New Drug Therapies, Innovative Management Strategies, and Novel Drug Targets * ADA Diabetes Symposium-Dementia and Diabetes * Diabetes Prevention Program Outcomes Study (DPPOS) 

Table of Contents for the Digital Edition of Scientific Sessions 2014 Preliminary Program

Scientific Sessions 2014 Preliminary Program

https://www.nxtbookmedia.com